Andy Crew
Keine laufenden Positionen mehr
Profil
Andy Crew worked as a Senior Director at OSI Pharmaceuticals and Astellas Pharmaceuticals SA from 2002 to 2013.
He was also a Principal Scientist at Knoll Pharmaceutical Co. from 1990 to 1996.
Later, he worked as a Senior Vice President-Chemistry at Arvinas Operations, Inc. and Arvinas, Inc. from an unknown date to 2019.
Dr. Crew holds a doctorate degree from The University of Liverpool.
Ehemalige bekannte Positionen von Andy Crew
| Unternehmen | Position | Ende |
|---|---|---|
| OSI PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.01.2013 |
| Astellas Pharmaceuticals SA | Direktor/Vorstandsmitglied | 01.01.2013 |
| Knoll Pharmaceutical Co. | Corporate Officer/Principal | 01.01.1996 |
| ARVINAS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Arvinas Operations, Inc.
 Arvinas Operations, Inc. BiotechnologyHealth Technology Arvinas Operations, Inc. develops novel therapeutics for the treatment of cancer, pro-inflammatory, autoimmune and rare diseases. It offers proteolysis-targeting chimera PROTAC-based drugs that induce protein degradation to target and eliminate disease-causing proteins from the body. The company was founded by Craig M. Crews in July 2013 and is headquartered in New Haven, CT. | Corporate Officer/Principal | - |
Ausbildung von Andy Crew
| The University of Liverpool | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ARVINAS, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Arvinas Operations, Inc.
Arvinas Operations, Inc. BiotechnologyHealth Technology Arvinas Operations, Inc. develops novel therapeutics for the treatment of cancer, pro-inflammatory, autoimmune and rare diseases. It offers proteolysis-targeting chimera PROTAC-based drugs that induce protein degradation to target and eliminate disease-causing proteins from the body. The company was founded by Craig M. Crews in July 2013 and is headquartered in New Haven, CT. | Health Technology |
OSI Pharmaceuticals, Inc.
 OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OSI Pharmaceuticals, Inc. manufactured and develope dpharmaceutical drugs. The company was founded in 1983 and was headquartered in Farmingdale, NY. | Health Technology |
| Astellas Pharmaceuticals SA | |
| Knoll Pharmaceutical Co. |
